# CJ CheilJedang: A disappointing year, but set to benefit from base effects and a stronger won next year

> Hana Securities kept its Buy rating and 370,000-won target price for CJ CheilJedang, forecasting year-on-year profit declines in the third and fourth quarters. The firm expects operating profit to recover next year and reports plans to sell its starch and sweetener business and three China feed subsidiaries, plus a joint venture with ADM in amino acid production.

- Date: 2026-11-03 · published 2026-11-03T03:11:12.510Z
- Category: market · region South Korea · magnitude low
- Page: https://feedsoft.ai/events/76932-cj-cheiljedang-a-disappointing-year-but-set-to-benefit-from-base-effects-and-a
- Commodities: [Lysine](https://feedsoft.ai/c/LYSINE.md)

## Why it matters

The planned sale of China feed units and the ADM amino acid joint venture could reshape amino acid supply over time, but the effect on feed commodity prices is limited in the near term.

## Sources

- en.fnnews.com: https://en.fnnews.com/news/202611030901142775

---
Data from Feedsoft AI (https://feedsoft.ai/). For information only; not investment advice.